Guiding Covid policy: cost-benefit analysis and beyond

被引:1
|
作者
Aldred, Jonathan [1 ]
机构
[1] Emmanuel Coll Cambridge, Studies Econ, Cambridge, England
关键词
Covid; Coronavirus; Cost-benefit analysis; Consequentialism; Precautionary principle; STATISTICAL LIFE; PREFERENCES;
D O I
10.1093/cje/beac011
中图分类号
F [经济];
学科分类号
02 ;
摘要
Cost-benefit analysis (CBA) is inappropriate as an aid to Covid policy-making because the plural, incommensurable values at stake are not all amenable to monetary measurement. CBA for Covid policy is also undermined by pervasive uncertainty and ignorance, and has some troubling distributional implications. However, non-consequentialist alternatives to CBA tend towards implausibly absolutist prohibitions on risk imposition. Arguments for setting aside consequentialism for special circumstances (the precautionary principle, or a medical rule of rescue) are also problematic when applied to Covid policy. A broad consequentialist approach to policy guidance is defended, one which does not demand commensuration on a common monetary scale. Despite the absence of commensuration, policy guidance is still possible.
引用
收藏
页码:589 / 608
页数:20
相关论文
共 50 条
  • [21] A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia
    Lopez, Francesc
    Catala, Marti
    Prats, Clara
    Estrada, Oriol
    Oliva, Irene
    Prat, Nuria
    Isnard, Mar
    Valles, Roser
    Vilar, Marc
    Clotet, Bonaventura
    Argimon, Josep Maria
    Aran, Anna
    Ara, Jordi
    VACCINES, 2022, 10 (01)
  • [22] Well-Being and Fair Distribution: Beyond Cost-Benefit Analysis
    Raterman, Ty
    ETHICS, 2013, 123 (03) : 545 - 549
  • [23] The Cost-Benefit Fallacy: Why Cost-Benefit Analysis Is Broken and How to Fix It
    Flyvbjerg, Bent
    Bester, Dirk W.
    JOURNAL OF BENEFIT-COST ANALYSIS, 2021, 12 (03) : 395 - 419
  • [24] Well-Being and Fair Distribution: Beyond Cost-Benefit Analysis
    Vallentyne, Peter
    ANALYSIS, 2013, 73 (03) : 542 - 548
  • [25] BEYOND APPEARANCE: ORIGINAL VS GENERIC ANTICOAGULANTS COST-BENEFIT ANALYSIS
    Figallo, M.
    Manrique, S.
    Colunge, N.
    Castaneda Aliaga, D.
    Chavez, M.
    Marrugo, R.
    Lopez, C.
    VALUE IN HEALTH, 2022, 25 (07) : S376 - S376
  • [26] Beyond cost-benefit analysis: the search for a comprehensive evaluation of transport investment
    Vickerman, Roger
    RESEARCH IN TRANSPORTATION ECONOMICS, 2017, 63 : 5 - 12
  • [27] Cost-Benefit Analysis in Reasoning
    Alaoui, Larbi
    Penta, Antonio
    JOURNAL OF POLITICAL ECONOMY, 2022, : 881 - 925
  • [28] Beware the cost-benefit analysis
    Spence, Des
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [29] Incommensurability and cost-benefit analysis
    Adler, M
    UNIVERSITY OF PENNSYLVANIA LAW REVIEW, 1998, 146 (05) : 1371 - 1418
  • [30] In Defence of Cost-Benefit Analysis
    Ergas, Henry
    AGENDA-A JOURNAL OF POLICY ANALYSIS AND REFORM, 2009, 16 (03) : 31 - 40